Parallel evolution of Pseudomonas aeruginosa phage resistance and virulence loss in response to phage treatment in vivo and in vitro. (2022)
Attributed to:
Does CRISPR-Cas immunity limit the effectiveness of phage therapy?
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7554/elife.73679
PubMed Identifier: 35188102
Publication URI: http://europepmc.org/abstract/MED/35188102
Type: Journal Article/Review
Volume: 11
Parent Publication: eLife
ISSN: 2050-084X